Anxiety Clinical Trials
There are 978 actively recruiting anxiety clinical trials across 69 countries. Studies span Not Applicable, Phase 2, Phase 3, Phase 4, Phase 1, Early Phase 1. Top locations include Boston, Massachusetts, United States, Los Angeles, California, United States, New York, New York, United States. Updated daily from ClinicalTrials.gov.
Anxiety Trials at a Glance
978 actively recruiting trials for anxiety are listed on ClinicalTrialsFinder across 6 cities in 69 countries. The largest study group is Not Applicable with 652 trials, with the heaviest enrollment activity in Boston, Los Angeles, and New York. Lead sponsors running anxiety studies include Massachusetts General Hospital, Macquarie University, and Monash University.
Browse anxiety trials by phase
Top cities for anxiety trials
Understanding Anxiety Disorder Clinical Trials
Clinical trials have been responsible for every major breakthrough in anxiety treatment, from the development of SSRIs like paroxetine (Paxil) in the 1990s to the recent FDA clearance of new targeted therapies. Today, researchers are testing novel approaches that go beyond traditional antidepressants, including drugs that act on the glutamate system, psychedelic-assisted therapies, and digital therapeutics. For the estimated 40 million adults in the United States affected by anxiety disorders each year, clinical trials represent a path to treatments that may work faster, produce fewer side effects, or help when current medications have fallen short.
Why Consider a Clinical Trial?
Frequently Asked Questions
Common questions about Anxiety clinical trials
It depends on the specific study. Some trials require a washout period where you taper off current medications under medical supervision before starting the investigational treatment. Others allow you to continue your existing regimen and add the study treatment on top. The study team will explain all medication requirements before you enroll.
Clinical trials cover the full spectrum of anxiety disorders, including generalized anxiety disorder (GAD), social anxiety disorder, panic disorder, specific phobias, and agoraphobia. Some trials focus on a single diagnosis while others enroll participants with multiple anxiety-related conditions. You can filter trials by your specific diagnosis when searching.
Many anxiety trials use placebo-controlled designs where some participants receive an inactive pill. However, you will always be told before enrolling whether a placebo group exists. In some studies, all participants eventually receive the active treatment through a crossover design. No one will ever secretly switch your current effective medication to a placebo.
Most anxiety treatment trials run between 8 and 16 weeks for the active treatment phase, though some extend to 6 or 12 months to study long-term effects. Screening and follow-up periods add additional time. The full commitment is always outlined in the informed consent document before you agree to participate.
The investigational treatment and study-related procedures are typically provided at no cost. Some trials also cover the cost of related lab work and doctor visits. However, routine care costs not directly related to the study may still be billed to your insurance. Many trials also offer compensation for your time and travel expenses.
Showing 1–20 of 978 trials